Clinical Trial Update: A Study of LY8888AX in Participants Using a Connected Insulin Management Platform [NA]

View source ↗

Summary

A completed clinical trial evaluating LY8888AX in participants using a connected insulin management platform; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• LY8888AX

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes, Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2025-11-10